KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...
KANSAS CITY, Kan., June 29, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Releaseâ„¢ (PTRâ„¢) drug delivery platform ...
The computational function of the dACC has remained perennially controversial 1,2,3,4,5. Many points of disagreement stem from differential weightings across a body of empirical findings that can be ...